Abivax SA (AAVXF)
15.15
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Abivax Total Liabilities (Quarterly): 144.86M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 144.86M |
| June 30, 2023 | 98.45M |
| June 30, 2023 | 98.45M |
| December 31, 2022 | 73.30M |
| June 30, 2022 | 68.49M |
| June 30, 2022 | 68.49M |
| December 31, 2021 | 94.31M |
| June 30, 2021 | 62.74M |
| June 30, 2021 | 62.74M |
| December 31, 2020 | 65.68M |
| June 30, 2020 | 45.22M |
| June 30, 2020 | 45.22M |
| December 31, 2019 | 37.12M |
| June 30, 2019 | 38.30M |
| Date | Value |
|---|---|
| June 30, 2019 | 38.30M |
| December 31, 2018 | 22.18M |
| June 30, 2018 | 5.734M |
| June 30, 2018 | 5.734M |
| December 31, 2017 | 6.760M |
| June 30, 2017 | 4.599M |
| June 30, 2017 | 4.599M |
| December 31, 2016 | 4.102M |
| June 30, 2016 | 4.218M |
| June 30, 2016 | 4.218M |
| December 31, 2015 | 4.953M |
| June 30, 2015 | 9.894M |
| June 30, 2015 | 9.894M |
| December 31, 2014 | 4.901M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
37.12M
Minimum
Dec 2019
144.86M
Maximum
Dec 2023
69.44M
Average
65.68M
Median
Dec 2020
Total Liabilities (Quarterly) Benchmarks
| DBV Technologies SA | 34.24M |
| Cellectis SA | 249.58M |
| PHAXIAM Therapeutics SA (DELISTED) | -- |
| Genfit SA | 117.09M |
| Innate Pharma SA | 146.24M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 361.53M |
| Shareholders Equity (Quarterly) | 216.67M |